Nathan Pennell, MD, PhD of Cleveland Clinic gives an overview of his abstract, which focused on the use of maintenance pembrolizumab in patients with extensive stage small cell lung cancer at the 2017 ASCO Annual Meeting in Chicago, IL.
Abstract 8504: Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts)
Advertisement